Key facts
- Lunair Medical’s last known valuation is $29.0M (Jun 2023).
- It has raised $27.5M across 1 recorded rounds; the latest was Early Stage VC ($7.5M) in Aug 2025.
- Notable investors include SV Health Investors, Deerfield Management, Deerfield Catalyst.
- Lunair Medical has filed 1 Form D with the SEC, most recently Sep 2025 ($7.5M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Lunair Medical
Funding rounds
1 roundsAbout Lunair Medical
Developer of a novel therapy designed to treat obstructive sleep apnea. The company's therapy for obstructive sleep apnea restores normal airflow during sleep without the need for external devices or oral appliances, enabling patients to have better overall health and restful sleep.
- Sector
- Healthcare
- HQ
- Minneapolis, MN, United States
- Founded
- 2023
- Employees
- 15
- Website
- lunairmedical.com/
- Ownership
- Privately Held (backing)
Lunair Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lunair Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lunair Medical in its N-PORT filings yet. We sweep new filings monthly.